Business · 08/06/2001Updated: 10/17/2026 · 1 min read
Endocrinologic and Metabolic Drugs Advisory Committee to Hold Meeting on Upcoming Date
Summary
The Endocrinologic and Metabolic Drugs Advisory Committee will convene for a scheduled meeting, as previously announced, to discuss and provide recommendations on various endocrinologic and metabolic drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →